Known, unknown, and estimated
GHK-Cu search results often mix cosmetic products, laboratory findings, and systemic protocol claims. This page separates those contexts and leaves unsupported pharmacokinetic values unknown.
Published research context
A peer-reviewed review discusses GHK-Cu in skin remodeling and related biological research.
Human pharmacokinetics
A suitable route-specific human half-life, Tmax, exposure curve, and exact personal concentration are not established here.
Optional model assumptions
Any user-selected curve input is exploratory and must remain separate from measured or established human PK.
Why the human half-life remains unknown
A review can summarize biological research without being a pharmacokinetic trial. The cited source does not provide a suitable route-specific human half-life, concentration-time curve, Tmax, or validated systemic exposure model. Repeating a precise-looking number would create false certainty.
Topical product record
Preserve the exact product label, formulation, stated concentration, application event, and observation.
Systemic claim boundary
Do not infer systemic exposure, safety, or an appropriate protocol from topical marketplace availability.
Cosmetic regulation boundary
FDA generally does not pre-approve cosmetic products or ingredients other than certain color additives.
Observation boundary
A timestamped observation is useful context, but it does not establish efficacy, causality, or product identity.
Topical presence is not proof of an approved systemic therapy
In the United States, product claims and intended use affect whether a product is regulated as a cosmetic, a drug, or both. FDA states that it generally does not pre-approve cosmetic products or ingredients, except certain color additives. A tracker should record the product and route as labeled without upgrading marketplace presence into an approval claim.
Keep GHK-Cu product and route context attached to every event
Halflife - Peptide & GLP-1 Log can preserve identity, route, event, supply, observation, and evidence notes. The dedicated guide keeps topical records separate from unsupported systemic assumptions.
What a responsible GHK-Cu record includes
Record the exact product or source label, formulation, route, date, time, amount or application description as stated, supply identifier, and timestamped observations. If an exploratory model is used, record the source, route, assumption, and limitation directly beside it.
What this page deliberately does not provide
This page does not provide an injection protocol, systemic dose, treatment recommendation, clearance time, or claim that GHK-Cu treats a condition. A tracker cannot authenticate a product, establish safety or efficacy, or convert a non-PK review into human pharmacokinetic evidence.
Common questions
What is the half-life of GHK-Cu?
A suitable route-specific human pharmacokinetic half-life is not established by the cited review. The human value should remain unknown unless a suitable PK source is documented.
Can a topical GHK-Cu record use a systemic half-life curve?
Not responsibly by default. Topical application and systemic exposure are different contexts, and a suitable route-specific human value is not established here.
Is GHK-Cu FDA-approved because it appears in cosmetic products?
No such conclusion follows. FDA generally does not pre-approve cosmetic products or ingredients other than certain color additives, and intended-use claims affect regulatory classification.
What can a GHK-Cu tracker establish?
It can organize the exact product, route, event, supply, observation, and selected evidence note entered by the user. It cannot establish product identity, efficacy, safety, or exact personal exposure.
References and source boundaries
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Curr Aging Sci. 2008;1(3):200-209. PMID 18690916. Open PubMed record.
- U.S. Food and Drug Administration. Cosmetics and U.S. Law. FDA explains cosmetic and drug definitions and that cosmetics generally are not pre-approved, except certain color additives. Open FDA page.
Turn the evidence boundary into a cleaner record
Halflife - Peptide & GLP-1 Log keeps events, schedules, supplies, sites, observations, and model assumptions together while leaving measurements and clinical decisions to qualified care.